Matthew Foster

Corporate Officer/Principal presso ALLENA PHARMACEUTICALS, INC.

Health Technology

Profilo

Matthew Foster is currently the Chief Restructuring Officer at Allena Pharmaceuticals, Inc. since 2022.
Prior to this, he held the position of Chief Restructuring Officer at Argos Therapeutics, Inc.

Posizioni attive di Matthew Foster

Società	Posizione	Inizio
ALLENA PHARMACEUTICALS, INC.	Corporate Officer/Principal	02/09/2022

Tutte le posizioni attive di Matthew Foster

Precedenti posizioni note di Matthew Foster

Società	Posizione	Fine
ARGOS THERAPEUTICS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Matthew Foster

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Matthew Foster

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ALLENA PHARMACEUTICALS, INC.	Health Technology

Aziende private	1
Argos Therapeutics, Inc. Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC.	Health Technology